Adimmune, your trusted partner to global market
We tailor our services to customers’ needs and offer solutions for various scales, phases, and timelines. We are one of the key suppliers of high-quality vaccines and biologics around the world.
View All
Support Resilient
Supply for Vaccines
We engage with the WHO Pandemic Influenza Preparedness Framework to foster the development and access to vaccines. Recognized by US FDA and the EU, we tackle health challenges by leveraging our high standards of quality.
26 Aug. 2025
ANVISA’s GMP Certification Granted to Adimmune Significantly Advances the Progress toward Regulatory Approval in Brazil
Adimmune Corporation (4142) today announced that its Tanzi plant in Taichung has officially received Good Manufacturing Practice (GMP) certification from the Brazilian Health Regulatory Agency (ANVISA). The certification follows an on-site inspection conducted in June, during which ANVISA officials reviewed Adimmune’s influenza vaccine production process.
08 Aug. 2025
Adimmune Enhances Technical Capabilities and Expands CDMO Capacity
Adimmune Corporation (4142) announced today at its investor conference that the company has implemented operational adjustments in response to shifting global political and economic circumstances. In the first half of this year, Adimmune successfully passed inspections by Brazilian ANVISA and EMA respectively. To meet growing demand from clients for additional production capacity, the company’s existing facilities are operating at full load. Adimmune has therefore initiated the installation of a third automated aseptic filling line with an annual capacity of 4 million doses, designed to serve customized, small-batch, and high-value products, and provide end-to-end services from clinical trials to commercial manufacturing—enhancing both capacity and scheduling flexibility.
09 Jul. 2025
Adimmune Adopts QbD to Enhance Process and Product Development
Adimmune Corporation (TWSE: 4142) has been adopting Quality by Design (QbD) practices to align with international standards, enhance its capabilities in process and product development, support international CDMO (contract development and manufacturing organization) projects, and drive new business and technology expansion.
